针对癌症向治疗的小分子双重抑制剂向热冲击蛋白90
Xin Xie1, Nan Zhang2, Xiang Li3
1State Key Laboratory of Southwestern Chinese Medicine Resources, Hospital of Chengdu University of Traditional Chinese Medicine, College of Medical Technology and School of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China; Michael Smith Laboratories, University of British Columbia, Vancouver V6T 1Z4, Canada.
Bioorganic chemistry
|July 19, 2023
概括
热冲击蛋白90 (Hsp90) 在癌症中至关重要. 开发双位Hsp90抑制剂提供了一个有前途的策略,以克服药物耐药性和癌症治疗效率低等挑战.
科学领域:
- 分子生物学分子生物学
- 药品化学 药品化学 是一个
- 在瘤学瘤学.
背景情况:
- 热冲击蛋白90 (Hsp90) 是一个重要的分子伴侣,参与许多细胞过程.
- Hsp90是癌症治疗中验证的标,但Hsp90抑制剂面临临临床开发障碍,包括耐药性和毒性.
- 只有少数小分子Hsp90抑制剂获得了全球批准.
研究的目的:
- 审查Hsp90.0.的域结构和生物功能.
- 讨论Hsp90双抑制剂的设计,发现和结构-活性关系.
- 为临床药物研究和新型Hsp90双抑制剂的开发提供见解.
主要方法:
- 关于Hsp90在癌症中的作用的文献综述.
- 对现有的Hsp90抑制剂及其局限性的分析.
- 探索组合策略和双目标抑制剂设计.
主要成果:
- Hsp90抑制剂显示出有希望的结果,但与有效性和耐药性作斗争.
- 将Hsp90抑制剂与其他药物 (HDAC,图布林,Topo II抑制剂) 结合起来,可以产生协同作用的抗瘤效应.
- 双向的Hsp90抑制剂是提高功效和抗药耐药性的有效策略.
结论:
- 双向的Hsp90抑制剂是癌症治疗的一个有前途的方法.
- 对Hsp90双抑制剂的进一步研究可以促进癌症药物开发.
- 药物化学的观点对于发现新的Hsp90向剂至关重要.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K


